PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 8, 2026European Stroke Journal0 citationsOpen Access

Abstract Number: Esoc2026a1390 Less Is More: The Notch3-SVD Staging System Versus Serum Neurofilament Light as a Predictor for Disease Progression in Cadasil

View Full Paper
GGGido GravesteijnRHRemco J. HackMCMinne N. Cerfontaine

Key Points

  • To evaluate the predictive value of the NOTCH3-SVD staging system compared to serum neurofilament light in CADASIL disease progression.
  • Analyzed serum neurofilament light levels in 55 CADASIL patients at baseline and 2-year follow-up.
  • Used generalized linear models to assess associations with ischemic stroke, lacunes, and microbleeds across different models.
  • Accounted for age and NOTCH3-SVD stage when analyzing predictive factors.
  • Baseline sNfL predicted 2-year incident lacunes and microbleeds but not stroke (model 1).
  • Predictive effect of sNfL decreased when age was included (model 2).
  • NOTCH3-SVD stage was predictive for incident stroke, lacunes, and microbleeds in the combined model (model 3).

Abstract

Abstract Background and aims Disease progression in the genetic small vessel disease (SVD) CADASIL is highly variable, and was recently captured using the NOTCH3-SVD staging system: a tool for uniform disease staging using routine clinical and neuroimaging measures. Previously, serum Neurofilament Light-chain (sNfL) has been shown to predict disease progression in CADASIL, but requires expensive ultrasensitive assays. Here, we examined the association between sNfL and disease progression in a 2-year follow-up study of CADASIL patients, accounting for the NOTCH3-SVD stages. Methods sNfL values were determined in 55 patients at baseline and 2-year follow-up, using Simoa. Associations of incident ischemic stroke, lacunes, and microbleeds, with baseline sNfL (model 1), sNfL and age (model 2), and sNfL, age and NOTCH3-SVD stage (model 3) were determined using generalized linear models, and expressed as odds ratios (OR, for 1 sd or stage). Results Baseline sNfL values were predictive for 2-year incident lacunes and microbleeds, but not for stroke (model 1). The predictive effect of sNfL decreased after adjusting for age (model 2). In a combined model with NOTCH3-SVD stage and age (model 3), sNfL values were not predictive of incident events, whereas NOTCH3-SVD stage was predictive of incident stroke, incident lacunes, and incident microbleeds. Conclusions In CADASIL, a clinico-neuroradiological staging system outperforms the ultrasensitive biomarker sNfL in disease prediction. This study illustrates that the predictive value of the sNfL is mediated through age and NOTCH3-SVD stage in CADASIL, and highlights the importance of accounting for NOTCH3-SVD stage in CADASIL biomarker studies. Conflict of interest G. Gravesteijn, R.J. Hack, M.N. Cerfontaine, M.J.A Koel-Simmelink, C. Teunissen, J.W. Rutten, S.A.J. Lesnik Oberstein: nothing to disclose relevant to this project.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Gravesteijn et al. (2026) studied this question.

synapsesocial.com/papers/69fd7e42bfa21ec5bbf066c0https://doi.org/10.1093/esj/aakag023.095
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Serum neurofilament light chain in functionally relevant coronary artery disease and adverse cardiovascular outcomes2023 · 11 citations
  2. 2ABSTRACT NUMBER: ESOC2026A2128 SNFL AS AN EARLY PREDICTOR OF OUTCOME AFTER ENDOVASCULAR STROKE THERAPY2026
  3. 3Circulating levels of neurofilament light chain as a biomarker of infarct and white matter hyperintensity volumes after ischemic stroke2024 · 18 citations
  4. 4Genotype-phenotype correlations in a Scottish CADASIL cohort and comparison with sporadic small vessel disease2026
  5. 5Serum neurofilament light chain and multiple sclerosis prognosis: a systematic review and meta-analysis2026